NCT00684814View on ClinicalTrials.gov

Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Healthy
Interventions
DRUG

Zolpidem Tartrate 10 mg tablet

10 mg tablet administered after an overnight fast of at least 10 hours

DRUG

Zolpidem Tartrate 10 mg tablet (Ambien®)

10 mg tablet administered after an overnight fast of at least 10 hours

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00684814 - Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions | Biotech Hunter | Biotech Hunter